Dosage: 200-500 mcg, 1-2 times daily via subcutaneous injection or daily oral capsules
Navigating Initial Fatigue on Semaglutide Semaglutide, a GLP-1 weight loss medication, could cause some discomfort, such as fatigue, after you start taking it
A physician may need to evaluate persistent vomiting, severe abdominal pain, signs of dehydration, worsening reflux, gallbladder symptoms, low blood sugar risk in patients using diabetes medications, kidney function concerns, unintentional under-eating, rapid weakness or muscle loss, and medication interactions
Benefits Simple dosing Mild titration schedule Good for long-term glucose management Suitable for patients who prefer minimal dose changes Considerations Not approved for weight loss Weight reduction is typically more modest than with semaglutide or tirzepatide May cause nausea during dose increases As with Ozempic, some pharmacies charge more than others for Trulicity
Enforce a reasonable identifier pattern (e.g., alphanumeric, length bounds, no unsupported symbols) and trim leading/trailing spaces